Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.

2013 Year End Financial Results

Genmab reported its full year 2013 financial results and held a conference call on March 4.  Click the following links to access the archived call: Listen to the webcast; download the podcastdownload the slides.

Visit Our Download Library

Explore our Download library to access presentations given at investor and scientific conferences, financial reports, podcasts and more.  Visit our Image gallery to download corporate photos.

Sign Up to Receive Electronic Shareholder Communication

To register your e-mail address for electronic shareholder communication, including information about the annual general meeting, log on to the InvestorPortal